The optimal interval for post-vaccination serological test in infants born to mothers with positive hepatitis B surface antigen

The optimal interval for post-vaccination serological test in infants born to mothers with positive hepatitis B surface antigen

Postvaccination serologic testing (PVST) is utilized to monitor the success or failure of vaccination against hepatitis B virus (HBV) infection in infants of hepatitis B surface antigen (HBsAg) positive mothers. This secondary analysis of 1255 infants of HBsAg-positive mothers at 7–14 months age inc...

Full description

Bibliographic Details
Main Authors:	Hongyu Huang, Xuhui Zhang, Yuqian Luo, Jie Chen, Jing Feng, Yimin Dai, Yali Hu, Yi-Hua Zhou
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-12-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	hepatitis b vaccine anti-hbs non-response rate pvst interval infants hbsag-positive mothers
Online Access:	http://dx.doi.org/10.1080/21645515.2021.1992213

Similar Items

Seromarkers of Hepatitis B virus in newborns with HBsAg positive mothers
by: Yousef Yahyapour (PhD), et al.
Published: (2009-05-01)

Active-passive Immunization Effectiveness Against Hepatitis B Virus in Children Born to HBsAg Positive Mothers in Amol, North of Iran
Published: (2011-11-01)

HBsAg in Cord Blood Qf Newborns of HBsAg-Positive Mothers
by: Adnan S. Wiharta, et al.
Published: (2018-11-01)

Age-wise and Gender-wise Prevalence of Hepatitis B Virus (HBV) Infection in Lahore, Pakistan
by: Aqib Nazeer, et al.
Published: (2019-12-01)

Prevalence of Hepatitis B Surface Antigen in hospital based population in Bijapur, Karnataka
by: Sayed A. Quadri, et al.
Published: (2013-04-01)

An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression
by: Giuseppina Brancaccio, et al.
Published: (2021-04-01)

Analytical Performance of the Sysmex HISCL HBsAg Assay and Comparison with the Roche Elecsys HBsAg II Quant Assay in the Quantification of Hepatitis B Surface Antigen
by: Joonhong Park, et al.
Published: (2021-11-01)

Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report
by: Adriane Maira Delicio, et al.
Published: (2013-12-01)

A retrospective serological survey of hepatitis B virus infection in Northeast China
by: Jing Meng, et al.
Published: (2019-05-01)

Seroprevalence of Hepatitis B virus Infection by Quantitative Chemiluminescent in Tabriz (North West of Iran), 2010-2011
by: Nader Hajizadeh, et al.
Published: (2014-08-01)

Expression and purification of hepatitis B surface antigen S from <it>Escherichia coli</it>; a new simple method
by: Elghanam Mohamed S, et al.
Published: (2012-03-01)

Seroprevalence of hepatitis B surface antigen and its correlation with risk factors among new recruits in Turkey
by: Tulin Altay, et al.

Detecting Hepatitis B Surface Antigen Mutants
by: Paul F. Coleman
Published: (2006-02-01)

Prediction for HBsAg seroconversion in children with chronic hepatitis B
by: Yan-Wei Zhong, et al.
Published: (2021-12-01)

Comparative ELISA reagents for detection of hepatitis B surface antigen (HBsAg) Comparação de reativos para o teste de ELISA na evidenciação do antígeno de superfície de hepatite B
by: I. F. Camargo, et al.
Published: (1987-06-01)

Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)
by: Carla S. Coffin, et al.
Published: (2022-11-01)

Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon
by: Hong Li, et al.
Published: (2022-12-01)

Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention
by: Shuai-Wen Huang, et al.
Published: (2024-12-01)

Sero-prevalence of Hepatitis B Virus infection in Balochistan province of Pakistan
by: Nadeem S Sheikh, et al.
Published: (2011-01-01)

Occult hepatitis B virus infection: clearance or disguise?
by: Jin-Wook Kim
Published: (2014-09-01)

Quantitative of serum hepatitis B core antibody is a potential predictor of recurrence after interferon-induced hepatitis B surface antigen clearance
by: Yali Wu, et al.
Published: (2021-04-01)

Prevalencia de anticuerpos anti-VHC y del antígeno de superficie de la hepatitis B en pacientes tratados con hemodiálisis Prevalence of anti-HCV antibodies and of the hepatitis B surface antigen in patients treated with hemodialysis
by: Zuzet Martínez Córdova, et al.
Published: (2008-03-01)

Seroprevalence of hepatitis B surface antigen (HBsAg) in Bo, Sierra Leone, 2012–2013
by: Rashid Ansumana, et al.
Published: (2018-02-01)

Serological Evaluation of Hepatitis B Virus in Out Patient Department Patients of a Private Hospital in North-West India
by: Smita Sood
Published: (2013-09-01)

Low Level of Serum Immunoglobulin G Is Beneficial to Clinical Cure Obtained With Pegylated Interferon Therapy in Inactive Surface Antigen Carriers
by: Hong Li, et al.
Published: (2022-04-01)

Evolution of hepatitis B virus surface gene and protein among Iranian chronic carriers from different provinces
by: Fatemeh Ramezani, et al.
Published: (2015-11-01)

Accuracy Validation of the Elecsys HBsAg II Quant Assay and Its Utility in Resolving Equivocal Qualitative HBsAg Results
by: Jaehyeon Lee, et al.
Published: (2023-02-01)

Evaluación serológica de la inmunización pasiva-activa en la profilaxis de la transmisión perinatal de la hepatitis B
by: Marité Bello, et al.
Published: (2012-04-01)

Evaluating the Immunity against Hepatitis B Virus and Frequency of HBsAg Positive Cases among Medical Staff of Shahid Beheshti Hospital in Yasuj, 2016
by: MT Rezanejad, et al.
Published: (2017-12-01)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

Chronic carriers of hepatitis B surface antigen in an endemic area for schistosomiasis mansoni in Brazil
by: JC Serufo, et al.
Published: (1998-01-01)

Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B
by: Zhan-Qing Zhang, et al.
Published: (2017-12-01)

Long-term hepatitis B surface antigen kinetics after nucleos(t)ide analog discontinuation in patients with noncirrhotic chronic hepatitis B
by: Lina Wu, et al.
Published: (2024-09-01)

RNA Interference Therapy for Chronic Hepatitis B Predicts the Importance of Addressing Viral Integration When Developing Novel Cure Strategies
by: Christine I. Wooddell, et al.
Published: (2021-03-01)

Response of Preterm Infants of Mothers Who Are Chronic Carriers of Both HBsAg and HBeAg to Pre-52 Containing Hepatitis 8 Vaccine (TGP 943) - A Preliminary Report
by: Abdul Hamid Sutohardjo
Published: (2018-10-01)

Assessing risk of liver enzyme elevation in patients with immune-mediated diseases and different hepatitis B virus serostatus receiving anti-TNF agents: a nested case-control study
by: Ying-Ming Chiu, et al.
Published: (2017-11-01)

Durability of Hepatitis B surface antigen seroclearance in patients experienced nucleoside analogs or interferon monotherapy: A real-world data from Electronic Health Record
by: Zongqi Shi, et al.
Published: (2023-05-01)

Epidemiology of Chronic Hepatitis B Infection in the Cohort of College Students with Vaccination in Taiwan
by: Te-Wei Cheng, et al.
Published: (2023-02-01)

Functional cure for chronic hepatitis B: accessibility, durability, and prognosis
by: Aixin Song, et al.
Published: (2021-06-01)

Acute hepatitis B in pregnancy with surprisingly rapid clearance of serum HBs antigen associated with a favourable outcome
by: Steven Roger, et al.
Published: (2022-05-01)